Gastroenterology
The findings of a recent study suggest that a mixture of B. infantis and HMOs can modulate the gut microbiota in adults.
The findings of a recent study suggest that resistant-starch supplements can alter the gut microbiota in ways that alleviate NAFLD.
Microbial differences may help to identify targets that could be modulated to mitigate health inequities.
The interplay between micronutrients and the microbiome is a significant factor in determining the risk of vitamin and mineral deficiencies, which has implications for global public health.
This study demonstrated fundamental mechanisms through which A. muciniphila and L. plantarum modify the gut microbiota and control immune responses in the SLE mouse model.
The findings of a recent study suggest that (S)-IBD3540 is a promising approach for treating IBD in people.
This study highlights the potential risks associated with the use of nanoparticles in food production and processing.
The findings suggest that Dau-d4 can supplement current DPP4 treatment approaches for type 2 diabetes.
The findings of a recent study may help identify targets for the prevention or treatment of rheumatoid arthritis and other inflammatory conditions.
The findings of a recent study suggest that microbial consortia such as MET-2 may be effective strategies to keep intestinal pathogens and antibiotic-resistant organisms at bay.
